Merck Launches All-in-One Genetic Stability Assay for Biosafety Testing
Currently, FDA guidance requires biotech companies to use multiple assays to address genetic stability requirements. This traditional package of assays is costly, time-consuming, and often results in data that need additional interpretation and support. Aptegra addresses these pain points.